Fortrea Holdings Inc. (FTRE) — SEC Financial Statements & Analysis

Fortrea Holdings Inc. (FTRE) is a services-medical laboratories company. Fortrea Holdings Inc. trades on Nasdaq as: FTRE. Fortrea Holdings Inc. (FTRE)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29. Based on that filing, Fortrea Holdings Inc. carries a market cap of $1.65B, a P/E ratio of -19.36x, a P/B ratio of 3.15x, a P/S ratio of 0.62x, an enterprise value of $2.54B, and an EV/EBITDA multiple of 37.56x. On profitability, it posts a gross margin of 19.30%, an operating margin of -0.40%, a net margin of -3.18%, a Return on Equity (ROE) of -15.30%, a Return on Assets (ROA) of -3.07%, and a Return on Invested Capital (ROIC) of -0.67%. Per share, it reports EPS of $-0.90, diluted EPS of $-0.90, free cash flow per share of $2.07, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -2.09% year-over-year, net income growth of -91.70% year-over-year, and EPS growth of -92.07% year-over-year. On the balance sheet, it maintains a current ratio of 0.96x, a quick ratio of 0.85x, working capital of $-40.10M, a debt-to-equity ratio of 4.18x, a debt ratio of 0.81, an interest coverage ratio of -0.13x, free cash flow of $196.00M (TTM), and net debt of $885.70M. Figures sourced from SEC EDGAR.

Market Cap

$1.65B

P/E TTM

-19.36x

EPS TTM

$-0.90

P/B TTM

3.15x

ROE TTM

-15.30%

ROA TTM

-3.07%

Debt To Equity

4.18x

Free Cash Flow TTM

$196.00M

Net Revenue TTM Growth 1Y

-2.09%

Data as of 2026-06-30 · Source: SEC EDGAR